Aandeel INKSURE TECHNOLOGIES INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Inksure Technologies Inc. OTC Bulletin Board

Aandelen

US45727E1064

slotkoers OTC Bulletin Board
Andere beurzen
- USD - Intraday-grafiek van Inksure Technologies Inc.
2023 Manuka, Inc. rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI
2023 Manuka, Inc. Rapporteert winstresultaten voor het tweede kwartaal en de zes maanden eindigend op 30 juni 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Manuka Announces Review of Strategic Alternatives
Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Manuka, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ARTEMIS THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
Artemis Therapeutics Inc. Announces Executive Changes
Artemis Therapeutics : Opinion on the Financial Statements - Form 8-K
ARTEMIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Change in Shell Company Status, Financial Statements and Exhibits (form 8-K)
Manuka Ltd completed the acquisition of Artemis Therapeutics Inc. in a reverse merger transaction.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers MNKA
  4. Koers
  5. Nieuws Inksure Technologies Inc.
  6. Andere talen
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU